DMart promoter Radhakishan Damani has reasons besides snob value for buying plush Malabar Hill property, say experts
Experts explain the distinction between the rights of small and minority shareholders in public-listed and private companies
Business Standard brings you top news of the evening
Mistry said that he is disappointed by the Supreme Court verdict on his battle with Tata Sons
Now the Mistrys are not getting even a board seat on Tata Sons, and the court has left it to both parties to negotiate the exit price of Mistrys
Tata Group may offer an exit to Mistry family from Tata Sons on the basis of valuation chartered accountant Y H Malegam put in 2016.
There's room in India for a Tata super-app to compete with Mukesh Ambani's Reliance Industries Ltd
The court has made it clear that Mistry Group is not a small shareholder and a board seat cannot be allotted to it contractually or by law
Another legal battle over stake valuation must be avoided
Here's a selection of Business Standard opinion pieces for the day
Deciding on the valuation depends on the Mistry family, which is under pressure to pay off debts owed by their group.
The court said that it is up to Tata Sons, Mistry to take the legal route to resolve the issue of shares
Tata Group companies, on Friday, rallied up to 6 per cent in intra-day trade on the BSE post the Supreme Court ruling
Reacting to the apex court ruling, Ratan Tata in a tweet said, 'It is not an issue of winning or losing.'
The Supreme Court ruled in favour of Tata Sons in the Tata vs Mistry case, bringing quietus to the half-decade old legal battle which started in 2016
A bitter legal and public battle between the two sides erupted when Cyrus Mistry, the scion of the Mistry family, was removed from Tata Sons' board as chairman in October 2016 by its board
As per the Friday's cause list uploaded on the apex court website, a bench headed by Chief Justice S A Bobde would pronounce the verdict
Framework aims to guide startups and other companies on structuring terms and conditions
The startup procures generic medicines from around nine major pharmaceutical manufacturers
Pritish Nandy Communications on Monday said veteran industrialist Ratan Tata has invested in the company